Home Details
| Official Symbol of Gene | TNFSF10 |
| Species | Homo sapiens |
| Entrez Gene ID | 8743 |
| Official Full Name | TNF superfamily member 10 |
| Also known as | TL2; APO2L; CD253; TANCR; TRAIL; Apo-2L; TNLG6A |
| Gene Type | protein coding |
| dbXrefs | Ensembl:ENSG00000121858 MIM:603598; AllianceGenome:HGNC:11925 |
| Map Location | 3q26.31 |
| Detected Sample | venous blood |
| Sample Detail | N/A |
| Detected Method | ELISA |
| Disease | MS |
| Disease subtype | RRMS |
| Population | N/A |
| Sample Size | 53 relapsing-remitting Egyptian MS patients and 25 matched healthy volunteers |
| Pubmed ID | 24913933 |
| Year | 2014 |
| Title | Role of serum TRAIL level and TRAIL apoptosis gene expression in multiple sclerosis and relation to brain atrophy |
| Expression | up-regulation |
| Risk type | Disease risk |
| Result | No significant correlation was detected between the serum TRAIL level and the TRAIL mRNA expression ratio in either group. No statistically significant correlation was found between serum TRAIL levels or the TRAIL mRNA expression ratio with the number of black holes or the bicaudate ratio on MRI. Apoptosis of T lymphocytes is decreased in MS patients, which could be useful when designing treatments. There was no difference in the TRAIL mRNA gene expression ratio between MS patients and controls |
| Mechanism/Pathway | The tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) molecule is among the potential biomarkers in MS |

2023,CopyRight © HMU. College of Bioinformatics Science and Technology, Harbin, China.